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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S441differentiate into a chondrogenic lineage. Transforming Growth Factor-
b (TGFb) has a crucial role in chondrogenesis and can either signal via
type I receptor ALK5 or ALK1 in chondrogenic cells. Downstream ALK5
and ALK1 lead to different intracellular signaling routes; Smad2/3 and
Smad1/5/8 respectively. As TGFb is required for induction of chondro-
genic differentiation, we wondered whether TGFb could by itself alter
the receptor expression of ALK1 and ALK5, thereby modulating its own
signaling pathway.
Methods: Human BMSCs and dedifferentiated ACs were chondrogeni-
cally (re)differentiated in pellet culture in serum-free chondrogenic
medium containing 10nM dexamethasone and 25 mg/mL ascorbic acid,
with or without 10 ng/mL TGFb1. Pellets were harvested after 1, 4, 7, 14,
21, 28 and 35 days of chondrogenic induction for transcript analysis.
Relative mRNA levels of ALK1, ALK5, collagen type II and aggrecan were
measured using Q-RT-PCR. Values were corrected for ribosomal protein
S27a. To further evaluate the quality of the extracellular matrix
deposited by the cells, pellets were harvested after 21 and 35 days and
stained with Safranin O/Fast Green (proteoglycans) or immunostained
for collagen type II. An unpaired sample T-test was performed between
TGFb-stimulated and unstimulated pellets (n ¼ 3 pellets per time
point).
Results:Only pellets stimulatedwith TGFb displayed chondrogenesis as
measured by gene expression of collagen type II and aggrecan, and
immunohistochemical staining for proteoglycans and collagen type II.
Contrary to unstimulated pellets that were devoid of cartilage-like tis-
sue. In unstimulated BMSCs, ALK1 expression was upregulated during
the ﬁrst 4 days of culturing, while this upregulationwas absent in TGFb-
stimulated pellets. As a result, ALK1 expression remained stably lower
(w4-fold; p < 0.01) in the TGFb-stimulated compared to the unstimu-
lated condition from day 4 until the end of the culture period. In con-
trast, ALK5 expression was continuously increased by TGFb within the
ﬁrst 14 days of induction, remaining constantly higher (w10-fold; p <
0.001) than in unstimulated pellets during the remainder of the culture.
In pellets formed with dedifferentiated ACs, ALK1 expression rapidly
decreased in TGFb-stimulated pellets and stayed at a lower (w3-fold; p
< 0.01) level than in the unstimulated pellets until day 35. Expression of
ALK5 was higher (w10-fold; p < 0.0001) in ACs stimulated with TGFb
than in the control condition on day 1. After day 1, ALK5 expression
remained higher (w2-fold; p < 0.05) in TGFb-stimulated pellets com-
pared to unstimulated pellets, although the difference became smaller
with time during AC redifferentiation.
Conclusions: Our data show that TGFb modulates ALK1 and ALK5
expression in chondrogenic cells by stimulating ALK5 expressionwhilst
dampening ALK1 expression. This shows that TGFb not only directly
induces chondrogenic differentiation, but that it also modulates the
signaling pathways itself by altering the expression of the TGFb type I
receptors, ALK5 and ALK1 favoring ALK5. Unraveling the role and reg-
ulation of these receptors will help us to further improve the formation
of stable cartilage by BMSCs.
799
EARLY INTRA-ARTICULAR INJECTION OF MESENCHYMAL STEM CELLS
PREVENTS SYNOVIAL INFLAMMATION AFTER MEDIAL MENISCAL
RELEASE IN A RABBIT MODEL OF OSTEOARTHRITIS
C. Boulocher y, N. Saulnier z, S. Maddens z, E. Pillet y, T. Roger y,
E. Viguier y. yVetAgro Sup, Veterinary Campus of Lyon, Marcy l’Etoile,
France; zVetbiobank, Marcy l’Etoile, France
Purpose: Osteoarthritis (OA) is characterized by a catabolic and
inﬂammatory joint environment. One of the main objective in the
management of OA is to dampen local inﬂammation in an attempt to
slow down cartilage degradation process and to relieve pain. Until
recently, Mesenchymal Stromal Cell (MSC) therapies for OA treatment
have mainly relied on their chondrogenic properties for cartilage repair.
The anti-inﬂammatory and immunomodulatory properties of Umbilical
Cord-Derived MSC (UC-MSC) has been rarely studied in the context of
the onset of the disease.
In the present study, we investigated the anti-inﬂammatory and anti-
catabolic effects of UC-MSC in a rabbit model of ﬁrst stage mild OA. We
examined the differential ability of an early or delayed intra-articular
(IA) injection of UC-MSC in preventing synovial inﬂammation, one of
the ﬁrst events leading ultimately to cartilage damage. The interactions
between MSC and the synovial membrane with regards to MSC anti-
inﬂammatory potentials were evaluated especially by analyses of the
expression of genes related to inﬂammation and matrix turnover. Thenature of the effects of UC-MSC on stimulated synoviocytes were fur-
ther investigated in vitro.
Methods: Medial meniscal release (MMR) was performed in rabbit
knee joints (day 0). A single early or delayed intra-articular (IA)
injection of UC-MSC was realized (day 3 or 15). At day 56, gross
morphology, Equilibrium Partitioning of an Ionic Contrast agent via
micro-CT (EPIC-mCT) and histology were performed to grade OA
lesions. Gene expression of inﬂammatory cytokines and metal-
loproteases was measured, in synovial tissue harvested from the OA
knees. In order to study the paracrine effects of UC-MSC, control rabbit
primary synoviocytes were incubated with UC-MSC-conditioned
medium or control medium under pro-inﬂammatory stimulus for 48 h
(Il-1b (10ng/ml)).
Results: As expected, at day 56, MMR procedure leads to changes con-
sistentwith earlyOA in themedial compartmentof the rabbit knee joints.
Cartilage ﬁbrillation, inﬂammatory cytokines and metalloproteases
gene expressions were lower in the early IA group than in the delayed
group. OA synovium gene expression analysis showed a reduction in the
expression of both the inﬂammatory cytokines (IL1b, TNFa) and the
metalloproteases (MMP-1, -3, -13) in the early-injected group com-
pared to the MMR group. UC-conditioned medium exerted anti-
inﬂammatory and anti-catabolic effects synoviocytes stimulated with
Il-1b. These results conﬁrmed UC-MSC possess paracrine activity that
target stimulated synoviocytes.
Conclusions: This study shows the efﬁciency of a single early IA
injection in preventing OA signs in rabbit knee following MMR. Early
UC-MSC IA injection might be more efﬁcient to reduce inﬂammation
and prevents OA progression than delayed UC-MSC IA injection.
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MAPPING OF THE WNT PATHWAY IN OSTEOARTHRITIC AND
HEALTHY SUBJECTS REVEALS AN INHERENTLY ALTERED PATTERN
IN OSTEOARTHRITIS MESENCHYMAL STEM CELLS
J.R. Lamas, A. Peralta-Sastre, P. Tornero-Esteban,
L. Rodríguez-Rodríguez, E. Herranz, B. Fernandez-Gutierrez. Hosp.
Clínico San Carlos (IdISSC), Madrid, Spain
Purpose: Osteoarthritis (OA) is characterized by homeostatic alter-
ations, resulting in abnormal restoration of damaged joint tissues by
progenitor mesenchymal stem cells (MSCs). Role of WNT signaling is
crucial in this process regulating MSCs proliferation and differ-
entiation to the osteogenic and chondrogenic lineages, the main
structural cell types of the joint. Using a targeted gene array, we aimed
to describe the expression ﬁngerprint of this pathway in OA patho-
genesis mapping the Wnt pathway integrity in MSCs and mature
chondrocytes.
Methods: Total RNA from MSCs and mature chondrocytes (C) cell cul-
tures was isolated from 10 OA patients (OA-MSCs ¼3 and OA-C ¼ 7) and
11 healty controls (MSCs ¼ 8 and C ¼ 3). Analysis of differential tran-
script expression of two metalloproteases, two collagen genes and 20
genes mapping the WNT signal transduction pathway were evaluated
using real-time quantitative PCR.
Results: Compared with healthy MSCs, expression of the transcription
factor gene LEF1 and the WNT5A ligand were signiﬁcantly down-
regulated and ADAMTS4 and BMP2 were upregulated in OA-MSCs.
Healthy mature chondrocytes showed an upregulation of BMP2, SOX9
and JUN. Downregulation of the JUN transcription factor concomitant
with an upregulation of kinases CSNK1A1 and GSK3Bwas present in OA-
Chondrocytes compared with healthy chondrocytes that also showed
an upregulation of LRP5 correceptor compared with OA-MSCs.
Conclusions: Expression of WNT related genes show a pattern of var-
iation in expression among MSCs and chondrocytes from OA and
healthy samples that point to inherent alterations in OA-MSCs that
determine their future chondrogenic phenotype in terms of a more
reduced chondogenic potential and an increased catabolic environ-
ment.
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SYNOVIAL ACTIVATION DRIVES ANIT-INFLAMMATORY EFFECTS OF
ADIPOSE-DERIVED STEM CELLS AFTER LOCAL ADMINISTRATION IN
EXPERIMENTAL OA WHICH IS REFLECTED BY S100A8/A9 LEVELS IN
THE SERUM
P. van Lent y, R. Schelbergen y, S. van Daalen y, A. Blom y, J. Roth z,
T. Vogl z, C. Jorgensen x, W. van den Berg y. yRadboud Univ. Med. Ctr.,
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S442Nijmegen, Netherlands; zDep of Immunology, IKM, Munster, Germany;
x Inserm U844, Hosp. Saint-Eloi, Montpellier, France
Purpose: Synovitis is evident in a substantial subpopulation of
patients with early osteoarthritis (OA) and has been associated with
development of pathophysiology. Recently we have shown that adi-
pose-derived stem cells (ASC) inhibit joint destruction after local
application to knee joints with experimental OA. We now explored the
effect of synovitis on the immunomodulatory capacity of ASCs after
local administration in two experimental OA models differing in
synovitis.
Methods: ASCs were isolated from fat surrounding the popliteal lymph
nodes. ASCs were injected into knee joints after induction of collage-
nase-induced OA (CiOA) characterized by synovitis and surgically
induced destabilized medial meniscus (DMM)model inwhich synovitis
is scant. Synovial activation, chondrogenesis in ligaments and osteo-
phytes were measured using histology. Cytokines in synovial washouts
and serumwere determined using Luminex. Active TGFbwas measured
using the CAGAluc assay.
Results: ASCs injected into knee joints at different time-points after
induction of DMM (day 7, day 14 or day 7 and day 14) had no effect
on development of ligament damage or osteophyte formation. In
contrast, ASC treatment of collagenase-induced OA knee joints, rap-
idly inhibited synovitis and ligament damage when administered at
day 7 after induction. Washouts of synovium taken at different time
points after injection of ASCs (6 hrs, day 2, day 14 and day 42)
showed signiﬁcantly decreased levels of IL-1b and S100A8/A9
already at 48 hrs after ASC treatment. No effect was found on levels
of active TGFb. Serum levels of S100A8/A9 were signiﬁcantly
decreased (85% lower) at day 14 whereas IL-1 levels were not
detectable anymore at that time-point. Next, we explored the effect
in CiOA in a condition with less synovial inﬂammation. Synovial
thickness at day 42 was 62% lower when compared to the former
study. Injection of the same dose of ASCs at day 7 after induction of
CiOA, only marginally inhibited synovial thickening when measured
at day 42. Serum levels of S100A8/A9 were low at day 14 (around 50
ng/ml compared to 800 ng/ml in the ﬁrst experiment) and were not
altered by the ASC treatment. Chondrogenesis in collateral and cru-
ciate ligaments but also osteophyte formation at the bone margins
was also not diminished.
Conclusions: Synovial activation rapidly drives anti-inﬂammatory
effects of ASCs after local administration in murine OA knee joints with
synovitis protecting against development of ligament damage and
osteophyte formation.
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IDENTIFICATION AND CHARACTERIZATION OF NOVEL STEM/
PROGENITOR CELLS IN RAT ADULT ARTICULAR CARTILAGE
A.N. Tran y, M-D. Truong y, B.H. Choi z, S.R. Park z, B-H. Min y,x. yDept. of
Molecular Sci. and Technology, Ajou Univ., Suwon, Republic of Korea;
zDept. of Physiology, Inha Univ. Coll. of Med., Incheon, Republic of
Korea; xDept. of Orthopedic Surgery, Sch. of Med., Ajou Univ., Suwon,
Republic of Korea
Purpose: Several recent studies suggested that a progenitor cell pop-
ulation which resides in cartilage exhibits stem cell relevant markers,
shows a phenotypic plasticity and generates chondrogenic, adipogenic,
and osteogenic lineages. They also provided some evidences of a stem/
progenitor cell niche within the articular cartilage. However, there is
still no deﬁnitive identity of these cells understood clearly in terms of
their surface markers and speciﬁc characters. The aim of this study is to
identify and characterize stem/progenitor cells exist in adult articular
cartilage in rats based on their differences in surface marker expression
before culture expansion.
Methods: Chondrocytes were isolated from rat adult cartilage in a
conventional manner using a collagenase treatment. Isolated cells were
subjected to ﬂow cytometry to investigate expression pattern of
selected surface markers of mesenchymal stem cells (CD29, CD34,
CD44, CD49e, CD73, CD90, CD105, CD106 and CD166). MSCs markers
which showed low expression in chondrocytes were used to sort out a
sub-population of cells, which was assumed to be a stem/progenitor
cells in the cartilage. The sub-population of cells isolated was furtherexamined for cell identity, multipotent differentiation ability, telomer-
ase activity and surface marker proﬁles.
Results: Analysis for the MSCs markers revealed that CD49e and CD90
were not expressed highly in uncultured rat chondrocytes. Rare pop-
ulations of CD49e- or CD90-positive cells were isolated successfully
showed better proliferation ability than unsorted total population of
cells. In particularly, they showed differentiation potential into different
lineages; CD49e-positive cells had higher adipogenic potential, and
CD90-positive cells had higher chondrogenic potential than each other.
They also expressed most of MSCs markers on their surface but the
expression level of CD49e and CD90 was decreasing along with pas-
sages after monolayer culture. Immunohistochemical analysis showed
that CD49e-positive cells lined particularly along the superﬁcial layer of
rat articular cartilage.
Conclusions: These results suggest that CD49e-positive and/or CD90-
positive cells could be a stem/progenitor cells in rat articular cartilage.
Further studies are needed to prove their identity and physiological role
in vivo.
This research was supported by the Bio & Medical Technology
Development Program of the National Research Foundation (NRF)
funded by the Ministry of Science, ICT & Future Planning (NRF-2011-
0019730).
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MSC BASED THERAPY FOR SEVERE OSTEOARTHRITIS OF THE KNEE. A
PHASE 1 DOSE ESCALATION TRIAL
C. Jorgensen, U. Noeth, A. Facchini, F. Barry, L. Sensebe, L. Casteilla,
D. Noel, G. Lisignoli. INSERM, Montpellier, France
a- Purpose: Among the degenerative diseases associated with aging,
osteoarthritis (OA) is the most common pathology which affects 16% of
the female population over 65 years. ASC are adult stem cells exhibiting
functional properties that have open the way for cell-based clinical
therapies. Primarily, their capacity of multilineage differentiation has
been explored in a number of strategies for skeletal tissue regeneration.
More recently, ASC have been reported to exhibit immunosuppressive
as well as healing capacities, to improve angiogenesis and prevent
apoptosis or ﬁbrosis through the secretion of paracrine mediators. Up to
now, no therapeutic option exists to obtain a sustainable improvement
of joint function beside knee arthroplasty. This prompted us to propose
adipose-derived mesenchymal stromal cells (ASC) as a possible cell
therapy.
b-Methods: We used 2 pre-clinical models of OA, and showed that a
local injection of ASC allowed a reduction of synovitis, reduction of
osteophytes, joint stabilization and reduction of the osteoarthritic score.
This work was completed by toxicology data showing the excellent
tolerance of the local injection of ASC and biodistribution showing the
persistence of cells after 6 months in immunodeﬁcient murine model.
In addition, quality control and tolerability of the injection of ASC led to
the approval by AFSSAPS in France and by the PEI in Germany to con-
duct the phase I clinical trial. The patient received a single injection of
autologous ASC, 15 days after lipoaspiration (2.106, 107 or 5.107 cells)
through intra-articular injection.
c- Results: The ADIPOA project started in January 2010 with the goal to
develop a new cell-based strategy for patients suffering from knee OA.
In this open-label phase I trial, we included 18 patients with severe OA
of the knee in failure of conventional therapies (62.5% were KL IV) at
two sites, Montpellier and Wurzburg. Mean age was 61 years, with a 10
years history of knee OA. The primary outcomemeasure of effectiveness
was patient-reported WOMAC pain subscores by VAS in the affected
knee at week 12. Secondary outcome measures included Outcome
Measures in Rheumatology Clinical Trials and Osteoarthritis Research
Society International (OMERACT OARSI) responses. We observed a
decrease of the VAS Pain (7311 mm day 0 to 3223 month 3), and of
WOMAC (5018 to 257 month 3).
d-Conclusions: This study conﬁrms the feasibility and safety of local
injection of autologous cells from adipose tissue and suggests that the
most effective dose was 107 autologous cells.The ADIPOA research
teams performed successfully the phase I clinical trial in France and
Germany. A phase IIB controlled trial is scheduled to conﬁrm the clinical
beneﬁt of this strategy.
